It’s a sobering statistic: 1 in 8 women in the United States will be diagnosed with breast cancer during her lifetime.1 ...

Researchers sought to determine the effect of changes in screening guidelines on incidence of breast cancer by stage at diagnosis and surgical management.

Treatment for breast cancer may take many forms ... According to ACS, women at average risk should follow these guidelines: ...

Genetic testing is recommended for those with personal and family histories of several types of cancer — including pancreatic ...

A new resource from the National Comprehensive Cancer Network (NCCN) provides evidence-based guidance on assessing and ...

Breast cancer is the second leading cause of cancer death in women. Early detection results in 99% five-year survival rates.

One in eight women will suffer from breast cancer in their lifetime. Eight percent will decline treatment due to the fear of alopecia. Regular physical activity prior to a cancer diagnosis lowered ...

AstraZeneca said the U.S. Food and Drug Administration approved Datroway, a treatment for metastatic breast cancer developed in combination with Daiichi Sankyo.

The incidence of in situ breast cancer has decreased since 2009, consistent with decreasing use of mammography in association ...

Today, the National Comprehensive Cancer Network (NCCN)-an alliance of leading cancer centers-published a new resource to inform people about the latest recommendations around hereditary and familial ...